0.38% -0.002

Bausch Lomb Corp (BLCO)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Bausch Lomb Corp Stock (BLCO) Company Profile

Bausch Lomb Corp

Healthcare (1166)

908-541-5456

520 APPLEWOOD CRESCENT, VAUGHAN

Nächster Verdiensttermin

Neueste SEC-Einreichungen

BLCO's Discussions on Twitter

Vergleichen Sie BLCO mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
BLCO Bausch Lomb Corp	11.45	4.17B	4.79B	-317.00M	-59.00M	-0.91
ISRG Intuitive Surgical Inc	551.20	197.20B	8.71B	2.48B	1.75B	6.82
BDX Becton Dickinson Co	169.40	50.02B	20.87B	1.50B	2.59B	5.24
ALC Alcon Inc	85.17	42.88B	9.93B	1.12B	1.58B	2.25
RMD Resmed Inc	243.16	36.10B	5.02B	1.31B	1.56B	8.91
BAX Baxter International Inc	29.55	15.84B	11.89B	-560.00M	191.00M	-1.10

Bausch Lomb Corp Stock (BLCO) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-05-02	Bestätigt	H.C. Wainwright	Buy
2025-03-28	Herabstufung	Wells Fargo	Overweight → Equal Weight
2024-12-11	Herabstufung	Citigroup	Buy → Neutral
2024-12-02	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2024-10-15	Hochstufung	Evercore ISI	In-line → Outperform
2024-07-10	Eingeleitet	Raymond James	Outperform
2024-05-06	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2024-01-04	Herabstufung	Evercore ISI	Outperform → In-line
2023-12-12	Eingeleitet	Stifel	Hold
2023-10-03	Fortgesetzt	Evercore ISI	Outperform
2023-05-30	Fortgesetzt	Morgan Stanley	Equal-Weight
2023-03-09	Eingeleitet	Needham	Hold
2022-12-21	Eingeleitet	Barclays	Equal Weight
2022-09-12	Eingeleitet	H.C. Wainwright	Buy
2022-07-26	Eingeleitet	RBC Capital Mkts	Outperform
2022-06-24	Eingeleitet	Evercore ISI	Outperform
2022-06-06	Eingeleitet	Citigroup	Buy
2022-05-31	Eingeleitet	Deutsche Bank	Hold
2022-05-31	Eingeleitet	Goldman	Neutral
2022-05-31	Eingeleitet	Guggenheim	Buy
2022-05-31	Eingeleitet	JP Morgan	Neutral
2022-05-31	Eingeleitet	Jefferies	Buy
2022-05-31	Eingeleitet	Morgan Stanley	Equal-Weight
2022-05-31	Eingeleitet	Wells Fargo	Overweight
2022-05-11	Eingeleitet	Cowen	Outperform

Alle ansehen

Bausch Lomb Corp Aktie (BLCO) Neueste Nachrichten

Finanzdaten der Bausch Lomb Corp-Aktie (BLCO)

Bausch Lomb Corp (BLCO)

Bausch Lomb Corp Stock (BLCO) Company Profile

Vergleichen Sie BLCO mit anderen Aktien

Bausch Lomb Corp Stock (BLCO) Upgrades & Downgrades

Bausch Lomb Corp Aktie (BLCO) Neueste Nachrichten

Bausch & Lomb Corp (BLCO) Trading Down 3.41% on May 30 - GuruFocus

Cetera Investment Advisers Decreases Stock Holdings in Bausch + Lomb Co. (NYSE:BLCO) - Defense World

Public market insider buying at Bausch + Lomb (BLCO) - The Globe and Mail

Bausch + Lomb, Organon, Globalstar, Telephone and Data Systems, and nLIGHT Shares Skyrocket, What You Need To Know - Yahoo Finance

Bausch + Lomb’s SWOT analysis: stock outlook amid market challenges - Investing.com

Bausch + Lomb to Participate in the 2025 Jefferies Global Healthcare Conference - BioSpace

Bausch & Lomb shareholders approve board nominees and compensation - Investing.com

Bausch + Lomb shareholders elect 10 directors at annual meeting By Investing.com - Investing.com India

Bausch + Lomb shareholders elect 10 directors at annual meeting - Investing.com

Bausch + Lomb Announces 2025 Annual Meeting of Shareholders Results - Yahoo Finance

Bausch + Lomb (BLCO) Launches LUMIFY Preservative Free Eye Drops in the U.S. | BLCO Stock News - GuruFocus

Global Intraocular Lens Market to Witness Upsurge in Growth at a CAGR of ~5% by 2032 | DelveInsight - GlobeNewswire Inc.

Bausch + Lomb introduces Zenlens CHROMA HOA lenses By Investing.com - Investing.com Canada

Bausch + Lomb introduces Zenlens CHROMA HOA lenses - Investing.com

Bausch + Lomb Launches Zenlens® CHROMA HOA™ in the United States - The Joplin Globe

BLCO Q1 Earnings Call: Misses on Profit, Highlights Product Innovation and Tariff Uncertainty - Yahoo Finance

Bausch + Lomb Co. (NYSE:BLCO) Given Average Recommendation of “Hold” by Analysts - Defense World

Morgan Stanley Lowers Bausch + Lomb (NYSE:BLCO) Price Target to $12.00 - Defense World

Bausch + Lomb’s LuxLife Intraocular Lens Gains European CE Mark Approval - TipRanks

Bausch + Lomb (BLCO) Receives CE Mark for LuxLife Intraocular Lens | BLCO Stock News - GuruFocus

Bausch + Lomb Receives European CE Mark Approval for Preloaded LuxLife® Full Range of Vision Intraocular Lens - Stock Titan

Bausch & Lomb (BLCO) Price Target Lowered by Morgan Stanley | BLCO Stock News - GuruFocus

Bausch & Lomb (BLCO) Price Target Lowered by Morgan Stanley | BL - GuruFocus

20,600 Shares in Bausch + Lomb Co. (NYSE:BLCO) Bought by Renaissance Technologies LLC - Defense World

Citigroup Issues Pessimistic Forecast for Bausch + Lomb (NYSE:BLCO) Stock Price - Defense World

Bausch & Lomb stock target cut to $15 at H.C. Wainwright By Investing.com - Investing.com South Africa

Bausch & Lomb stock target cut to $15 at H.C. Wainwright - Investing.com Nigeria

Bausch & Lomb (BLCO) Receives Adjusted Price Target by HC Wainwr - GuruFocus

Bausch & Lomb (BLCO) Receives Adjusted Price Target by HC Wainwright & Co. | BLCO Stock News - GuruFocus

Bausch + Lomb (BLCO) Price Target Cut by Analyst Amid Tariff Concerns | BLCO Stock News - GuruFocus

Citi Maintains Neutral Rating on Bausch & Lomb (BLCO), Lowers Pr - GuruFocus

Citi Maintains Neutral Rating on Bausch & Lomb (BLCO), Lowers Price Target | BLCO Stock News - GuruFocus

Bausch + Lomb (BLCO) Shares Plunge After Weak Q1 2025 Results - GuruFocus

Bausch & Lomb (BLCO) Target Price Lowered by Evercore ISI Group - GuruFocus

Bausch & Lomb (BLCO) Target Price Lowered by Wells Fargo | BLCO Stock News - GuruFocus

Bausch + Lomb Corporation (NYSE:BLCO) Q1 2025 Earnings Call Transcript - Insider Monkey

Bausch + Lomb (BLCO) Faces Price Target Cut Amid Financial Press - GuruFocus

Bausch + Lomb (BLCO) Sees Adjusted Price Target Amidst Earnings Update | BLCO Stock News - GuruFocus

Bausch + Lomb (BLCO) Reports Q1 Revenue Slightly Below Expectati - GuruFocus

Bausch + Lomb (BLCO) Faces Price Target Cut Amid Financial Pressures | BLCO Stock News - GuruFocus

Bausch + Lomb (BLCO) Price Target Reduced by Citi After Q1 Repor - GuruFocus

Bausch & Lomb Earnings: Amid Tariff and Recall Concerns, Shares Sink on Shaky Start to 2025 - Morningstar

Bausch + Lomb (BLCO) Misses Revenue Expectations in Q1, Shares D - GuruFocus

Bausch + Lomb (BLCO) Misses Q1 Estimates, Lowers Growth Outlook - GuruFocus

Bausch & Lomb Reports Weak Start to 2025 as enVista Recall, Tariffs, and Drug Pricing Cause Concerns - Morningstar

Bausch & Lomb Corp SEC 10-Q Report - TradingView

Bausch + Lomb stock hits 52-week low at $10.46 By Investing.com - Investing.com India

Bausch + Lomb stock hits 52-week low at $10.46 - Investing.com Australia

Bausch + Lomb shares tumble as Q1 earnings miss expectations By Investing.com - Investing.com Canada

Bausch + Lomb shares tumble as Q1 earnings miss expectations - Investing.com

Bausch + Lomb Announces First-Quarter 2025 Results - BioSpace

Finanzdaten der Bausch Lomb Corp-Aktie (BLCO)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie BLCO